DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 146 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.99 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,266,000 | -69.1% | 261,200 | -42.8% | 0.00% | -75.0% |
| Q2 2021 | $17,049,000 | -4.8% | 456,828 | -34.8% | 0.00% | 0.0% |
| Q1 2021 | $17,909,000 | -59.9% | 700,403 | -65.5% | 0.00% | -66.7% |
| Q4 2020 | $44,716,000 | +44.8% | 2,029,778 | +18.3% | 0.01% | +33.3% |
| Q3 2020 | $30,879,000 | +21.7% | 1,716,472 | +71.8% | 0.01% | 0.0% |
| Q2 2020 | $25,374,000 | -31.9% | 998,952 | -50.7% | 0.01% | -47.1% |
| Q1 2020 | $37,233,000 | -17.5% | 2,026,798 | -1.1% | 0.02% | -10.5% |
| Q4 2019 | $45,149,000 | +62.8% | 2,049,423 | +6.1% | 0.02% | +46.2% |
| Q3 2019 | $27,735,000 | -19.4% | 1,931,468 | -11.6% | 0.01% | -18.8% |
| Q2 2019 | $34,420,000 | +16.2% | 2,185,409 | +8.1% | 0.02% | +6.7% |
| Q1 2019 | $29,617,000 | +37.6% | 2,021,610 | +0.4% | 0.02% | +25.0% |
| Q4 2018 | $21,520,000 | -27.7% | 2,013,099 | +3.2% | 0.01% | -7.7% |
| Q3 2018 | $29,760,000 | +40.8% | 1,950,195 | +13.0% | 0.01% | +30.0% |
| Q2 2018 | $21,140,000 | +1195.3% | 1,725,715 | +910.7% | 0.01% | +900.0% |
| Q1 2018 | $1,632,000 | +566.1% | 170,741 | +1576.7% | 0.00% | – |
| Q1 2015 | $245,000 | – | 10,183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |